![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1372540
¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ´ë»ó : ÀǾàǰ À¯Çüº°, Á¦Ç°º°, Ç÷§Æûº°, ¼ºº°US Digital Pharmacy Market Size and Forecast (2020-2030), Regional Share, Trends, and Growth Opportunity Analysis Coverage: by Drug Type (Prescription Medicine and Over-the-Counter Medicine), Product, Platform, and Gender (Male and Female) |
¹Ì±¹ÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº 2022³â 672¾ï 4,200¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 2,402¾ï 1,600¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, 2022-2030³âÀÇ CAGRÀº 17.25%·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹Í ¶§ 󹿾àÀÇ ¿Â¶óÀÎ ±¸ÀÔ ±ÞÁõ°ú ¿Â¶óÀÎ Ç÷§Æû¿¡ ´ëÇÑ °æÇâÀÇ Áõ°¡´Â ¹Ì±¹ÀÇ µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¸î°³ÀÇ ¿äÀÎÀÔ´Ï´Ù.
Ç÷´ç ¸ð´ÏÅ͸µÀº ´ç´¢º´ °ü¸®ÀÇ Áß¿äÇÑ ºÎºÐÀÔ´Ï´Ù. Ç÷´ç ¸ð´ÏÅ͸µ¿¡´Â ÀϹÝÀûÀ¸·Î Ç÷´ç ÃøÁ¤±â ¶Ç´Â Ç÷´ç ÃøÁ¤±â°¡ »ç¿ëµË´Ï´Ù. ÀϹÝÀûÀ¸·Î ¼Õ°¡¶ô ³¡À» Âñ·¯ ¼Ò·®ÀÇ Ç÷¾×À» äÃëÇÏ¿© Ç÷´ç ÃøÁ¤±â ³»ºÎÀÇ Å×½ºÆ® ½ºÆ®¸³¿¡ ³õ½À´Ï´Ù. Ç÷´ç ¼öÄ¡´Â µ¥½Ã¸®ÅÍ´ç ¹Ð¸®±×·¥(mg/dl)À¸·Î ÃøÁ¤µÇ¸ç, ¾ÈÀüÇÑ Ç÷´ç ¼öÄ¡ÀÇ Ç¥ÁØ °¡À̵å¶óÀÎÀº 70-180mg/dlÀÔ´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ Ã³¹æ¾à ¿Â¶óÀÎ ±¸¸Å ±ÞÁõÀ¸·Î ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀå ¼ºÀå ÃËÁø
ASOP ¼¼°èÀç´ÜÀÌ 2020³â¿¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡ µû¸£¸é ¹Ì±¹ ±¹¹ÎÀÇ 50%°¡ ÆíÀǼº°ú ºñ¿ëÀû ÀÌÁ¡À¸·Î ÀÎÇØ ¿Â¶óÀÎÀ¸·Î ÀǾàǰÀ» ±¸¸ÅÇϰí ÀÖÀ¸¸ç, Abacus Data°¡ ¹Ì±¹ ¼ÒºñÀÚ 1,500¸íÀ» ´ë»óÀ¸·Î ½Ç½ÃÇÑ ¶Ç ´Ù¸¥ Á¶»ç¿¡ µû¸£¸é 2020³â¿¡ ¹Ì±¹ÀÎ 10¸í Áß 4¸í(42%)ÀÌ ¿Â¶óÀÎÀ¸·Î ÀǾàǰÀ» ±¸¸ÅÇϰí ÀÖÀ¸¸ç, 2020-2021³â±îÁö ÀǾàǰ ¿Â¶óÀÎ ±¸¸ÅÀÚ°¡ 7% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹³» ±¸¸Å µ¿ÇâÀ» º¸¸é °íÇ÷¾Ð, õ½Ä, ´ç´¢º´ µî ¸¸¼ºÀûÀ̰í Áö¼ÓÀûÀÎ Áúȯ¿¡ ó¹æµÇ´Â Á¦Ç°(Àüü ±¸¸ÅÀÇ 23%)ºÎÅÍ ¾Ï Ä¡·áÁ¦, È£¸£¸ó ´ëü¿ä¹ýÁ¦ µî Ư¼ö 󹿾à(°¢°¢ Àüü ±¸¸ÅÀÇ 11%)¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Ã³¹æ¾àÀ» ¿Â¶óÀο¡¼ ±¸¸ÅÇϰí ÀÖÀ½À» ¾Ë ¼ö ÀÖ½À´Ï´Ù. Çϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ 64%´Â 2021³â¿¡ óÀ½À¸·Î ¿Â¶óÀÎÀ¸·Î ÀǾàǰÀ» ±¸¸ÅÇßÀ¸¸ç, ÆÒµ¥¹ÍÀÌ Á¾½ÄµÈ ÀÌÈÄ¿¡µµ ¿Â¶óÀÎÀ¸·Î ÀǾàǰÀ» °è¼Ó ±¸¸ÅÇÒ ÀÇÇâÀÌ ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¿Â¶óÀÎ ÀǾàǰ ±¸¸Å¸¦ ¼±È£ÇÏ´Â ÁÖ¿ä ÀÌÀ¯´Â ±¸¸Å ÆíÀǼº, Á¦Ç° Á¢±Ù¼º, ó¹æ¾à ºñ¿ë Àý°¨(ÇÒÀÎ, Ưº° Çà»ç µî), healthinsurance.comÀÌ ½Ç½ÃÇÑ Á¶»ç¿¡ µû¸£¸é 2021³â¹Ì±¹ ¸ÞµðÄÉ¾î ¼öÇýÀÚ Áß ¿ø°ÝÀÇ·á ÀÌ¿ëÀÌ 340 Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. Áõ°¡µÈ ÀÌ¿ëÀÚÀÇ 33%´Â COVID-19 ÆÒµ¥¹Í ´ç½Ã ¿Â¶óÀÎ ¾à±¹À» ÅëÇØ 󹿾àÀ» ÁÖ¹®ÇÏ´Â °ÍÀ» ¼±È£ÇÑ´Ù°í ¹àÇû½À´Ï´Ù. ÀÌó·³ ó¹æ¾àÀÇ ¿Â¶óÀÎ ±¸¸Å¿¡ µû¸¥ µðÁöÅÐ ¾à»ç Áõ°¡´Â ±Þ¼ºÀåÇÏ´Â E-Commerce »ê¾÷°ú ¿Â¶óÀÎ ±¸¸Å·ÎÀÇ ´ë±Ô¸ð ¼ÒºñÀÚ Çൿ º¯È¿Í ÇÔ²² ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
½ÃÀå µ¿Çâ
À¥ ±â¹Ý ÅëÇÕ ¿Â¶óÀÎ ¾à±¹ ÀÎÅÍÆäÀ̽º°¡ ÁÖ¿ä Æ®·»µå·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.
¾à»ç¿Í ȯÀÚ°¡ Á¢±ÙÇÒ ¼ö ÀÖ´Â À¥ ±â¹Ý ¾à±¹ ÀÎÅÍÆäÀ̽º¿Í ÅëÇÕµÈ e-ÇコÄÉ¾î ½Ã½ºÅÛÀº ÇâÈÄ ¼ö³â°£ ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå·Î ºÎ»óÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¿Â¶óÀÎ ¾à±¹ÀÌ Á¦°øÇÏ´Â ¿Â¶óÀÎ ÀǾàǰ ±¸¸Å¸¦ Áö¿øÇÏ´Â ÇÁ·Î±×·¥Àº ÀÌ·¯ÇÑ ÀÎÅÍÆäÀ̽ºÀÇ ´ëÇ¥ÀûÀÎ ¿¹ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î Ä¡·áÀÇ ÀÏȯÀ¸·Î ½ºÅ¸Æ¾À» º¹¿ëÇϴ ȯÀÚ´Â ¾à¹° º¹¿ëÀ» Áß´ÜÇϰųª ºÒ±ÔÄ¢ÇÑ ÇൿÀ» ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ½ºÅ¸Æ¾À» ±â¹ÝÀ¸·Î ó¹æµÈ ÀǾàǰÀ» º¹¿ëÇÏ´Â »ç¶÷µé¿¡°Ô ¾à¹° ¼øÀÀµµ Áö¿øÀ» Á¦°øÇϵµ·Ï ÈÆ·ÃµÈ ¾à±¹ ÆÀ¿ø°úÀÇ ¾Ë¸² ¹× ¶óÀ̺ê äÆÃÀº ¾à¹° º¹¿ë Áß´ÜÀ» ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
Ç÷§Æû ±â¹ÝÀÇ ÀλçÀÌÆ®
Ç÷§Æû Ãø¸é¿¡¼ ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ¾Û ±â¹Ý°ú À¥»çÀÌÆ® ±â¹ÝÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾Û ±â¹ÝÀº ´Ù½Ã ¿ø°Ý °Ç° ¾à±¹ ¾Û, ¾à¹° °ü¸® ¾Û, °Ç° ¹× À£´Ï½º ¾Û, Á¶Á¦ ¾à±¹ ¾Û, ±âŸ·Î ¼¼ºÐȵ˴ϴÙ. ¾Û ±â¹Ý ºÎ¹®Àº 2022³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß 17.60%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ø°ÝÀÇ·á ¾à±¹ ¾ÛÀº 2022-2030³â »çÀÌ ¾Û ±â¹Ý ºÎ¹®¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2021³â ¹ßÇ¥µÈ CDC µ¥ÀÌÅÍ¿¡ µû¸£¸é 2020³â ¼ºÀÎÀÇ 37.0%°¡ ÀÇ·áÁø ¹æ¹®, ¿Â¶óÀΠó¹æ, Á¤½Å°Ç° ¼ºñ½º¸¦ Æ÷ÇÔÇÑ ¿ø°ÝÀǷḦ ÀÌ¿ëÇßÀ¸¸ç, ¿ø°ÝÀÇ·á ¾ÛÀ» ÅëÇØ ¾îµð¼³ª °¡»ó ÀÇ·á ¼ºñ½º¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ°íÀÇ ¿ø°ÝÀÇ·á ¾ÛÀº ¹«·á·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖ°í, »ç¿ëÇϱ⠽¬¿ì¸ç, º¸Çè ¼ºñ½º¸¦ ¿Ïº®ÇÏ°Ô º¸ÀåÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿ø°ÝÀÇ·á ¾à±¹ ¾ÛÀÇ ¸î °¡Áö ¿¹·Î´Â Hims & Hers, GoodRx, K Health, Doctor on Demand°¡ ÀÖÀ¸¸ç, GoodRx´Â Àúºñ¿ë ¹æ¹®, ¿ìÆíÀ» ÅëÇÑ °£ÆíÇÑ Ã³¹æÀü º¸Ãæ, °Ç° º¸ÇèÀÌ ¾ø´Â ¹æ¹® µîÀÇ ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.
ÀǾàǰ À¯Çü¿¡ µû¶ó ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº 󹿾à°ú ÀϹÝÀǾàǰÀ¸·Î ³ª´µ¸ç, 2022³â ÀǾàǰ ½ÃÀå Á¡À¯À²ÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß 17.83%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦Ç°º°·Î ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ÆÛ½º³ÎÄɾî, ºñŸ¹Î ¹× º¸ÃæÁ¦, ÀǾàǰ ¹× Ä¡·á, ±âŸ Á¦Ç°À¸·Î ±¸ºÐµË´Ï´Ù. ÀǾàǰ ¹× Ä¡·á ºÎ¹®Àº ´Ù½Ã¼º °Ç°, ½Å°æ Áúȯ, ½ÉÀå Áúȯ, ´ç´¢º´, üÁß °¨·®, ±âŸ·Î ¼¼ºÐȵ˴ϴÙ. ÀǾàǰ ¹× Ä¡·á ºÎ¹®Àº 2022³â Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ Áß 17.87%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ç÷§Æû Ãø¸é¿¡¼ ¹Ì±¹ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ¾Û ±â¹Ý°ú À¥ »çÀÌÆ® ±â¹ÝÀ¸·Î ºÐ·ùµË´Ï´Ù. ¾Û ±â¹ÝÀº ´Ù½Ã ¿ø°Ý °Ç° ¾à±¹ ¾Û, ¾à¹° °ü¸® ¾Û, °Ç° ¹× À£ºù ¾Û, Á¶Á¦ ¾à±¹ ¾Û, ±âŸ·Î ³ª´µ¸ç, 2022³â ¾Û ±â¹ÝÀÌ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß 17.60%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ºº°·Î´Â ³²¼º°ú ¿©¼ºÀ¸·Î ³ª´µ¸ç, 2022³â ½ÃÀå Á¡À¯À²Àº ¿©¼ºÀÌ ´õ Å©°í, ¿¹Ãø ±â°£ Áß 17.64%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The US digital pharmacy market is expected to grow from US$ 67.242 billion in 2022 to US$ 240.216 billion by 2030; it is expected to grow at a CAGR of 17.25% from 2022 to 2030. Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the US digital pharmacy market growth.
Monitoring blood sugar is a vital part of diabetes management. A glucometer or blood sugar meter is commonly used for blood glucose monitoring. It involves taking a small drop of blood, usually by pricking the fingertip and placing it on the test strip in a glucometer. Blood sugar levels are measured in milligrams per deciliter (mg/dl), with standard guidelines for safe blood sugar ranging from 70 to 180 mg/dl.
Upsurge in Online Purchase of Prescription Medicines During COVID-19 Pandemic Propels US Digital Pharmacy Market
According to a report published by the ASOP Global Foundation in 2020, nearly 50% of the American population purchased medicines online due to convenience and cost benefits. As per another survey conducted by Abacus Data on 1,500 American consumers, 4 in 10 Americans (42%) purchased medicines online in 2020, recording a 7% rise in the number of online buyers of medicines from 2020 to 2021. Moreover, purchase trends in the US indicate Americans buy an array of prescription drugs online, ranging from products prescribed against chronic and ongoing conditions (23% for all purchases), including high blood pressure, asthma, and diabetes, to specialty prescriptions such as cancer and hormone replacement therapy drugs (each accounting 11% of all purchases). Additionally, 64% of the individuals purchased medicines online for the first time in 2021, with intentions to continue buying online medicine even after the pandemic ends. The preference for online buying of medicines is mainly due to the convenience of buying, accessibility to products, and reduced cost of prescription medication (discounts, special offers, etc.). According to a survey conducted by healthinsurance.com, there was a 340% increase in telemedicine usage among Medicare recipients in the US in 2021. 33% of the increased users revealed that they preferred ordering prescription medicines through an online pharmacy during the COVID-19 pandemic. Thus, an increase in the number of digital pharmacists along with online purchases of prescription medicines, coupled with the rapidly spurring e-commerce industry and a massive shift in consumer behavior toward online purchases, favors the US digital pharmacy market growth.
Market Trend
Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend
Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the US digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.
Platform-Based Insights
In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.
Based on drug type, the US digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the US digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heartcare, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the US digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period..